Učitavanje...

Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma

In diffuse large B-cell lymphoma (DLBCL), many oncogenic microRNAs (OncomiRs) are highly expressed to promote disease development and progression by inhibiting the expression and function of certain tumor suppressor genes, and these OncomiRs comprise a promising new class of molecular targets for th...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Su, Yinghan, Sun, Bin, Lin, Xuejing, Zhao, Xinying, Ji, Weidan, He, Miaoxia, Qian, Haihua, Song, Xianmin, Yang, Jianmin, Wang, Jianmin, Chen, Jie
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226497/
https://ncbi.nlm.nih.gov/pubmed/27172795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9237
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!